Skip to main content

Market Overview

Agios Pharmaceuticals (NASDAQ: AGIO)

52.06 -0.18 (-0.34%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-1.43
34.706M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.59
87.098M



Q4 2020
Pre-Market
EPS:
REV:
-1.60
35.44M
-1.33
40.17M
-1.41
44.05M
-6.02%
9.66%
Q3 2020
Pre-Market
EPS:
REV:
-1.81
26.024M
-1.38
38.02M
-1.43
34.706M
-3.62%
-8.72%
Q2 2020
Pre-Market
EPS:
REV:
-1.87
26.221M
-1.37
37.71M
-1.31
37.347M
4.38%
-0.96%
Q1 2020
Pre-Market
EPS:
REV:
-1.59
30.227M
-1.67
30.83M
-0.59
87.098M
64.67%
182.51%
Q4 2019
Pre-Market
EPS:
REV:
-1.58
30.013M
-1.72
33.72M
-1.60
35.44M
6.98%
5.1%
Q3 2019
Pre-Market
EPS:
REV:
-1.63
15.198M
-1.80
32.99M
-1.81
26.024M
-0.56%
-21.12%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!